ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Senores Pharmaceuticals Limited plans to incorporate a new entity in Canada for pharmaceutical supply and distribution. The company will hold a majority 51% stake.
Senores Pharmaceuticals' US subsidiary has formed a strategic Joint Venture, Amerisyn, LLC, to supply the U.S. Federal Government and defense sectors. This partnership provides a gateway to high-entry-barrier military and veterans affairs contracts, positioning the group for significant international business growth.
Senores Pharmaceuticals Limited's US subsidiary has acquired a 70% stake in Amerisyn, LLC. Following this subscription, Amerisyn, LLC has become a step-down subsidiary of the company. This strategic move expanded the company's pharmaceutical footprint in the United States.
Senores Pharmaceuticals Limited's US subsidiary has formed a new joint venture, Amerisyn, LLC, in North Carolina. The company holds a 70% stake, making Amerisyn a step-down subsidiary. This expansion into the US pharmaceutical market signals a strategic growth move for the group.